Clin2
NCT07431437Possibly a fitEnrolling by invitation

GENOSS paclitaxel balloon for leg artery disease

PTA (Percutaneous Transluminal Angioplasty)Femoropopliteal Artery Disease

Part of Genetic & congenital, Heart & circulation clinical trials.

This trial tests a special balloon coated with paclitaxel (a drug that helps keep arteries open) in people with narrowed or blocked leg arteries. It aims to see how well the balloon works over one year.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
19 years to 85 years
Study type
Observational

Who can take part

  • You are 19 years or older.
  • You have leg symptoms like pain while walking, pain at rest, or sores on your foot or leg (Rutherford stages 2, 3, 4, or 5).
  • You have a blocked or narrowed artery in your upper leg or behind the knee (femoropopliteal area).
  • You are scheduled to have a balloon procedure to open that artery.
  • You have at least one open artery below the knee that supplies blood to your foot (with less than 50% narrowing).
  • You are not allergic to paclitaxel or any blood-thinning medicines.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07399080Enrolling by invitation
Study of a drug-coated balloon for leg artery disease

This trial is testing a special balloon coated with a drug (paclitaxel) to treat narrowed or blocked arteries in the leg. It aims to see how well this balloon works to keep the artery open.

Seoul
NCT07425171Recruiting
Testing a drug-coated balloon for long leg artery blockages

This trial is testing a special balloon coated with the drug paclitaxel to open up long blockages in the leg artery (femoropopliteal). The goal is to see if it is safe and effective for improving blood flow and symptoms like pain or ulcers.

Suwon, Gyeonggi-do
NCT07159087Enrolling by invitation
New drug balloon for re-narrowed stents

This trial tests a new drug-coated balloon (Genoss SCB) versus an existing one (SeQuent Please NEO) for people whose heart stents have re-narrowed. It aims to see which balloon better keeps the artery open.

Gyeonggi-do
NCT06734221Recruiting
Testing a paclitaxel-coated balloon for leg artery disease

This trial tests a special balloon coated with a drug (paclitaxel) to open blocked leg arteries, aiming to improve blood flow and reduce symptoms like leg pain when walking. It is for people with moderate to severe leg artery disease who have not had prior stents or bypass in the treated area.

Chrzanów, Malopolska
NCT07406308Not yet recruiting· Early Phase 1
Balloon with or without plaque removal for blocked leg arteries

This study compares two ways to open a completely blocked artery in the leg: using a paclitaxel-coated balloon alone, or first removing some blockage with a special device (debulking) before using the balloon. It aims to see which approach gives better long-term results for people with chronic leg artery blockages.

Beijing
NCT07385573Recruiting
Testing a drug-coated balloon for leg artery blockages

This trial tests a special balloon that releases medication to help keep leg arteries open. It's for people with narrowed or blocked arteries in the leg, either above or below the knee.

Aalst

Hear when a new Femoropopliteal Artery Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.